The status of the p53 gene can serve as a valuable biomarker in cancer diagnosis, prognosis, and treatment decisions. For instance, the presence of p53 mutations can indicate a more aggressive tumor and may influence the choice of therapeutic strategies. Additionally, monitoring p53 status can help assess treatment response and disease progression.
